Sanofi Said to Consider Smith & Nephew, Takeda for CEO
This article is for subscribers only.
Sanofi has considered Olivier Bohuon of medical-device maker Smith & Nephew Plc and Takeda Pharmaceutical Co.’s Christophe Weber as possible replacements for ousted Chief Executive Officer Chris Viehbacher, said people familiar with the situation.
The board of Paris-based Sanofi has started contacting potential candidates and wants to move quickly with the recruiting, said the people, who asked not to be identified discussing private matters. Eric Cornut, Novartis AG’s chief ethics officer, also is a potential candidate, as is Olivier Brandicourt, head of Bayer AG’s health-care business, some of the people said.